The enterprise digital pathology platform, powered by Tribun Health, integrates pathology, radiology, and cardiology imaging ...
Watchmaker Genomics launched a PCR-free whole genome sequencing workflow integrating library prep and normalization.
Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...
FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...
Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.
Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...
Agendia presented data on an AI pathology model that predicts breast cancer recurrence risk from routine biopsy slides.
FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...
Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.
Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...
Medicare now reimburses Lucid Diagnostics’ EsoGuard esophageal DNA test at $1,938 per test, following its $15 million private placement.
The acquisition adds a saliva assay for periodontal pathogen detection, extending the CLIA-certified laboratory’s services to dental practices. Real Diagnostics, a CLIA-certified clinical laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results